药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Chloroprocaine
Ozanimod
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Ozanimod.
Chloroprocaine
Triptolide
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Triptolide.
Chloroprocaine
Guselkumab
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Guselkumab.
Chloroprocaine
Sirukumab
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Sirukumab.
Chloroprocaine
Brodalumab
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Brodalumab.
Chloroprocaine
Peficitinib
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Peficitinib.
Chloroprocaine
Voclosporin
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Voclosporin.
Chloroprocaine
Pirarubicin
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Pirarubicin.
Chloroprocaine
Ravulizumab
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Ravulizumab.
Chloroprocaine
Ixekizumab
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Ixekizumab.
Chloroprocaine
Tepoxalin
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Tepoxalin.
Chloroprocaine
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Antilymphocyte immunoglobulin (horse).
Chloroprocaine
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Peginterferon beta-1a.
Chloroprocaine
Tixocortol
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Tixocortol.
Chloroprocaine
Dinutuximab
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Dinutuximab.
Chloroprocaine
Blinatumomab
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Blinatumomab.
Chloroprocaine
Vedolizumab
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Vedolizumab.
Chloroprocaine
Obinutuzumab
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Obinutuzumab.
Chloroprocaine
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Dimethyl fumarate.
Chloroprocaine
Teriflunomide
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Teriflunomide.